Christina M. Wyatt
- ASSISTANT PROFESSOR Medicine, Nephrology
MD, Duke University
BA, Duke University
MS, Columbia University
Mailman School of Public Health
Residency, Internal Medicine
Mount Sinai Hospital
Mount Sinai Hospital
ResearchClinical and research interests focus on acute and chronic kidney disease in patients with HIV and hepatitis C. Ongoing projects include a prospective research cohort in Mount Sinai's active HIV practice, as well as two studies investigating the utility of currently available GFR estimates in patients with HIV infection. Study objectives in the HIV cohort include description of the prevalence, incidence, and predictors of acute and chronic kidney disease in the era of antiretroviral therapy, as well as improved understanding of the impact of HCV co-infection on the risk for kidney disease.
Wyatt CM, Morgello S, Katz-Malamed R, Wei C, Klotman ME, Klotman PE, D'Agati VD. Acquired immunodeficiency syndrome and the spectrum of kidney disease in the era of antiretroviral therapy. Kidney Int 2009; 75: 428-434.
Jain CL, Wyatt CM, Burke R, Sepkowitz K, Begier EM. Knowledge of the CDC's 2006 Routine HIV Testing Recommendations among New York City internal medicine residents. AIDS Pat Care STD 2009; 23: 167-176.
Mocroft A, Wyatt CM, Et Al . Interruption of antiretroviral therapy is associated with increased plasma cystatin C. AIDS 2009; 23: 71-82.
Wyatt CM, Malvestutto C, Coca SG, Klotman PE, Parikh CR. The impact of hepatitis C virus co-infection on HIV-related kidney disease: A systematic review and meta-analysis. AIDS 2008; 22: 1799-1807.
Jain CL, Jue JS, Mackay R, Wallach F, Factor SH, Wyatt CM. Acceptance of rapid HIV testing among medical in-patients in New York City. AIDS Pat Care STD 2008; 22: 657-662.
Wyatt CM, Winston JA, Malvestutto C, Fishbein DA, Barash I, Cohen AJ, Klotman ME, Klotman PE. Chronic kidney disease in HIV infection: An urban epidemic. AIDS 2007; 21: 2101-2103.
Wyatt C, Konduri V, Eng J, Rohatgi R. Reporting of estimated GFR in the primary care clinic. Am J Kidney Dis 2007; 49: 634-641.
Wyatt C, Arons RR, Klotman PE, Klotman ME. Acute renal failure in hospitalized patients with HIV: Risk factors and impact on in-hospital mortality. AIDS 2006 Feb 28; 20(4): 561-5.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Wyatt during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.
- BioCryst Pharmaceuticals, Inc.; Bristol-Myers Squibb
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Annenberg Building Floor 23 Room 74
1468 Madison Avenue
New York, NY 10029